Cart
sales@molnova.com
Voacamine
CAS No. 3371-85-5
Voacamine ( Voacanginine )
Catalog No. M24284 CAS No. 3371-85-5
Voacamine is an indole alkaloid. Voacamine exhibits potent cannabinoid CB1 receptor antagonistic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 249 | In Stock |
|
| 10MG | 426 | In Stock |
|
| 25MG | 683 | In Stock |
|
| 50MG | 888 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVoacamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionVoacamine is an indole alkaloid. Voacamine exhibits potent cannabinoid CB1 receptor antagonistic activity.
-
DescriptionVoacamine is an indole alkaloid. Voacamine exhibits potent cannabinoid CB1 receptor antagonistic activity. Voacamine also inhibits P-glycoprotein (P-gp) action in multidrug-resistant tumor cells.Voacanginine may have rhythmic effects.
-
SynonymsVoacanginine
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCB1;P-gp
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3371-85-5
-
Formula Weight704.9
-
Molecular FormulaC43H52N4O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C(C1(C(C(C2)CC)N3CC2C1)C4=C(CC3)C(C=C(OC)C([C@H](CC(/C(CN5C)=C/C)C(C(OC)=O)[C@H]5C6)C7=C6C(C=CC=C8)=C8N7)=C9)=C9N4)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Condello M , Pellegrini E , Multari G , et al. Voacamine: Alkaloid with its essential dimeric units to reverse tumor multidrug resistance[J]. Toxicology in Vitro, 2020, 65:104819.
molnova catalog
related products
-
Hemopressin (rat)
Bioactive endogenous peptide substrate for endopeptidase 24.15 (ep24.15), neurolysin (ep24.16) and ACE. Ki values are 27.76, 3.43 and 1.87 μM respectively. Potent hypotensive in vivo. Also acts as a selective CB1 receptor inverse agonist. Displays antinociceptive activity and induces hypophagia in vivo.
-
EHP-101
VCE-004.8 is a specific dual agonist of PPARγ and CB2 receptor with potent anti-inflammatory activity. VCE-004.8 attenuates adipogenesis and prevents diet-induced obesity.
-
CB1-IN-4
CB1-IN-4 is a potent, selective, peripherally restricted cannabinoid-1 (CB1) receptor antagonist with Ki of 0.3 nM, EC50 of 3.0 nM.
